Predictions
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.23
17.09.23
17.09.23
-
17.09.24
17.09.24
-11.30%
02.10.23
02.10.23
Could be very worthwhile Investment >20% year
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.00
19.05.23
19.05.23
€2.20
19.05.24
19.05.24
-63.20%
01.10.23
01.10.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.85
03.09.23
03.09.23
-
03.09.24
03.09.24
-7.01%
16.09.23
16.09.23
Could be worthwhile Investment >10% per year
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.76
22.08.23
22.08.23
-
22.09.23
22.09.23
11.36%
04.09.23
04.09.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.98
21.08.23
21.08.23
-
21.08.24
21.08.24
-1.45%
02.09.23
02.09.23
Could be very worthwhile Investment >20% year
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.87
22.08.23
22.08.23
-
22.08.24
22.08.24
4.81%
02.09.23
02.09.23
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.70
22.08.23
22.08.23
-
22.08.24
22.08.24
15.29%
01.09.23
01.09.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.60
02.05.23
02.05.23
€12.00
02.05.24
02.05.24
-20.19%
27.08.23
27.08.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.08
07.08.23
07.08.23
-
07.08.24
07.08.24
-1.10%
19.08.23
19.08.23
Risky Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.96
28.07.23
28.07.23
-
28.07.24
28.07.24
-8.84%
05.08.23
05.08.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.48
13.07.23
13.07.23
-
13.07.24
13.07.24
-4.87%
22.07.23
22.07.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.01
06.07.23
06.07.23
-
06.07.24
06.07.24
4.55%
08.07.23
08.07.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.30
30.06.23
30.06.23
-
30.06.24
30.06.24
-12.52%
06.07.23
06.07.23
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.22
11.03.23
11.03.23
€4.60
11.03.24
11.03.24
18.48%
19.05.23
19.05.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€1.97
02.10.22
02.10.22
-
02.10.23
02.10.23
21.96%
18.05.23
18.05.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.87
24.03.23
24.03.23
-
24.03.24
24.03.24
12.58%
18.05.23
18.05.23
Could be very worthwhile Investment >20% year
Helius Medical Technologies Inc
Start price
Target price
Perf. (%)
€1.85
03.08.22
03.08.22
-
03.08.23
03.08.23
-92.76%
14.05.23
14.05.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.55
03.01.23
03.01.23
-
03.01.24
03.01.24
78.44%
14.05.23
14.05.23
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.86
27.10.21
27.10.21
€40.00
31.12.23
31.12.23
-59.32%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.45
18.10.21
18.10.21
€12.00
31.12.23
31.12.23
-2.68%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.49
10.10.21
10.10.21
€5.00
31.12.23
31.12.23
-32.83%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.46
04.01.23
04.01.23
€12.00
31.12.25
31.12.25
63.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.23
28.05.22
28.05.22
-
28.05.23
28.05.23
-56.27%
24.04.23
24.04.23
Probably not worthwhile Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.78
03.04.23
03.04.23
-
03.04.24
03.04.24
0.20%
15.04.23
15.04.23
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.79
20.09.21
20.09.21
-
20.09.25
20.09.25
-26.16%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year